New Study Will Assess Impact of COVID-19 Vaccination on Canadians with Immune-Mediated Inflammatory Disease

More than 7 million Canadians suffer from immune-mediated inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, psoriasis, and related conditions. The COVID-19 Immunity Task Force and Vaccine Surveillance Reference Group will supporting a nationwide study that will assess COVID-19 vaccine effectiveness, safety and vaccine hesitancy in this potentially vulnerable group of people.